Development asset linked to Shanghai General Hospital in public FDA and regional records.
pharma · Non Small Cell Lung Cancer
Shanghai General Hospital
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Shanghai General Hospital drug portfolio — 2 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.
CN HQ
NMPA registrant Type
Company details
- Status
- Public
- HQ
- CN
- Programs
- 1
- Drugs
- 2
- Patents
- 0
Shanghai General Hospital pipeline
Portfolio lens on 2 drugs and development assets — regulatory status, targets, and deep links to NovaPharmaNews drug profiles.
Shanghai General Hospital drug portfolio — 2 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.
Drug portfolio
-
-
Development asset linked to Shanghai General Hospital in public FDA and regional records.